The contribution of epigenetic mechanisms, primarily comprising microRNAs and modifications of DNA and histones, to rheumatoid arthritis (RA) is increasingly recognized. In this article, the authors discuss the role of the epigenetic machinery in this disease, with a particular focus on the enzymes that regulate protein acetylation, and the therapeutic potential of targeting these factors in RA. The authors suggest that returning to the original, broader definition of epigenetics, comprising all nongenetic regulatory mechanisms, might improve our understanding of disease and facilitate the development of novel therapeutic strategies.
- Aleksander M. Grabiec
- Kris A. Reedquist